Research & Recognition
Publications in leading journals such as Nature Chemistry, Nature Communications, and Science Advances.
Accessed over 25,000 times with 110 citations.
Research & Recognition
Media Kit available upon inquiry.
Research & Recognition
Over $3.2 million in grant-driven investment.
Our People
Grounded in a culture of research and entrepreneurship.
At the helm of innovation, Dr. Mata brings his extensive background in biomedical engineering and biomaterials from his tenure as Chair at the University of Nottingham. With a rich history in bioengineering, including his leadership in the Mineralized Tissue Group at IADR, underscores his pivotal role in driving Mintech-Bio’s technological advancements.
Steering Mintech-Bio towards its strategic goals, Pablo Brenes’ leadership is underpinned by his formidable experience in the corporate world, having held executive positions at GSK, P&G, and DHL. His acumen as an investor and board member in several startup ventures, coupled with an M.B.A. from the Kellogg School of Management at Northwestern University, positions him as a key driver of Mintech-Bio’s commercial success.
Dr. Ruiz’s role in product innovation is vital, leveraging her Ph.D. in bioprinting and regenerative medicine to ensure Mintech-Bio’s offerings are at the forefront of technological advancement and market needs. Her background as a practitioner of general dentistry informs her innovative work and professional leadership.
Our People
Leaders in clinical research, innovation, and industry.
Chief Dental Officer of Sonicare and ESPE (now 3M), international expert in chronic disease/caries management, and advisor to industry start-ups. Dr. Berg’s experience in industry, particularly in product development and clinical research, and as a clinician informs his strategic and operational guidance.
“Our success at Sonicare wasn’t solely driven by marketing to the consumer, but primarily by understanding the needs of dental professionals, our ambassadors to patients.”
Dr. JOEL BERG, DDS, MS, CEO OF EXECUDENT, INC., MINTECH-BIO BOARD MEMBER & KEY ADVISOR
Serving as CEO of Neurochase Ltd., Sharon brings a wealth of experience from the healthcare and financial growth sectors, offering strategic insights into Mintech-Bio's business development.
"Visionary leadership and seizing strategic opportunities are key to the financial success of any venture. Mintech-Bio is committed to leveraging their unique technology to capture market share and deliver long-term value and transform oral health care."
SHARON KANE, CEO OF NEUROCHASE, LTD., MINTECH-BIO BOARD MEMBER & KEY ADVISOR
A Professor of Finance at the Kellogg School of Management and DePaul University, Dr. Liberti’s expertise in finance supports Mintech-Bio’s financial strategy and growth planning.
As Professor and Chair of Restorative Dentistry and Director of Biomaterials and Biomechanics at Oregon Health & Science University, Dr. Ferracane provides Mintech-Bio with a deep understanding of restorative dentistry and materials science.
Recognized for his principal oral surgery practice and role as Division Chief at Mercy Hospital South. Dr. Gray’s extensive clinical experience enriches Mintech-Bio’s approach to oral healthcare solutions.
“As an Oral Surgeon and entrepreneur deeply invested in the evolution of dental technology, I recognize the paramount importance of innovation that resonates with both practitioners and patients. The ideal product is one that not only sets a new standard in clinical excellence, but also enhances the patient experience through comfort and ease of use. This is that product!”
DR. WILL GRAY, D.M.D., M.D., PRINCIPAL ORAL SURGEON OF ST. LOUIS SOUTH, ORAL & CRANIOFACIAL SURGERY DIVISION CHIEF OF MERCY HOSPITAL, SOUTH, ENTREPRENEUR, MINTECH-BIO KEY ADVISOR
Company & Technology News
Mintech-Bio has been granted a patent for our innovative technology. This is the third patent that Mintech-Bio has been granted in the course of developing our breakthrough remineralization technology, demonstrating commitment to and significant progress in our research and development.
We are pleased to announce the official operational launch of our Nottingham, United Kingdom-based research and development laboratory. Led by Dr. Alvaro Mata, Chief Scientific Officer of Mintech-Bio, as well as Dr. Abshar Hasan (Head of Research) and Dr. Laura Ruiz (Head of Product Innovation), this first-in-class facility will serve as the initial hub of R&D operations. In the coming months we will work to establish US-based R&D operations in strategic partnerships with leaders in innovation and research.
We are happy to announce our partnership with Execudent, Inc., a consultancy specializing in launching new brands and companies in the dentistry and oral healthcare sectors. This partnership will leverage Execudent's expertise in the dental industry to help Mintech-Bio bring new dental products to market. Execudent's services include value proposition articulation, competitive analysis, market research, go-to-market strategy development, and brand development. By partnering with Execudent, Mintech-Bio can increase its chances of success in launching new dental products. To learn more, visit www.execudent.com.
Mintech-Bio is guided by an experienced and accomplished Board of Directors. Pablo Brenes brings vast expertise in business development and strategic planning. Dr. Alvaro Mata offers invaluable insights into the biotechnology landscape. Dr. Joel Berg provides critical knowledge of dental medicine and clinical applications. Sharon Kane, CEO of Neurochase Ltd, brings a wealth of experience in leading innovative healthcare companies. Together, this board possesses the skills and vision necessary to steer Mintech-Bio towards success.
Company & Technology News
Mintech-Bio proudly introduces Dr. Jack Ferracane, Abhishek Gautam, Dr. Will Gray, Dr. Jayakumar Jayaraman, Sharon Kane, and Dr. José Liberti as new key advisors. Their diverse expertise in business engineering and dentistry will accelerate Mintech-Bio's mission to transform global oral healthcare with innovative solutions like the Epinamel remineralization gel. This strategic move aims to leverage their collective knowledge in restorative dentistry, organizational transformation, oral surgery, pediatric dentistry, and strategic financial planning to advance Mintech-Bio's vision for the future of oral health.
Mintech-Bio is delighted to announce new strategic partnerships with Execudent Inc. and US Capital, promising a significant boost to its growth and development in the dental and oral healthcare sectors. These collaborations will enhance Mintech-Bio's capabilities in strategic consulting, brand development, and securing essential funding for innovation and market expansion, aligning with its mission to revolutionize oral healthcare through cutting-edge regenerative dental technologies.
Mintech-Bio has proudly appointed Dr. Joel Berg and Dr. Sherif Elsharkawy to our Advisory Board, adding distinguished expertise in dentistry to its team. These appointments underscore our commitment to revolutionizing oral healthcare through regenerative dental technologies, aiming to improve dental health, patient confidence, and quality of life globally.
Thanks for submitting!
